2/23/2026 12:14:38 PM UPC Court of Appeal: ATE insurance can eliminate the need for security for costs By Nischay Mall Naoise Gaffney On 18 February 2026, the UPC Court of Appeal set aside an order for security for costs of €2 million, holding that the Munich Local...
2/23/2026 11:48:22 AM Bristows’ SnippITs: It can be expensive to drive a different car (McLaren v Alpa Racing) By Freya Ollerearnshaw Naomi Foale This post is the latest in Bristows’ SnippITs series, which pulls together the key practical takeaways from recent court decisions for...
2/23/2026 9:55:26 AM Irides: Weekly global patent litigation update By Gregory Bacon Andrew Bowler Olivia Henry Ewan MacAulay Hannah Rigby +2 more... Show less This edition features updates from: The United Kingdom, China and the Unified Patent Court (UPC). The Irides Weekly Update is our...
2/20/2026 10:13:57 AM Podcast: Patenting trends in women’s health By Maria Ryan Melissa Dix In this episode of our Spotlight on Women's Health and Innovation podcast, Maria Ryan and Melissa Dix explore how patenting trends offer...
2/20/2026 9:54:10 AM Podcast: UK Supreme Court rewrites the rules on patentability of Computer Implemented Inventions By Richard Pinckney Naoise Gaffney In today's podcast, Richard Pinckney and Naoise Gaffney disseminate the key takeaways from the Supreme Court's decision in Emotional...
2/18/2026 9:25:18 AM Qualcomm wins again on chips and royalties as UK competition collective action is withdrawn By Sophie Lawrance The UK collective proceedings regime received another indication today of the challenges to standalone abuse of dominance claims, as...
2/18/2026 8:33:11 AM AI-generated client docs are not privileged (says US Court) By Freya Ollerearnshaw In the US case of United States v Heppner, a Federal Judge ruled that AI-generated documents produced by the Defendant and subsequently...
2/16/2026 10:23:40 AM Irides: Weekly global patent litigation update By Claire Phipps-Jones James Boon Maria Ryan Jonathan Ross Naoise Gaffney Lucy Sewter +3 more... Show less This edition features updates from: The United Kingdom, Germany and the Unified Patent Court (UPC). The Irides Weekly Update is our...
2/16/2026 10:21:16 AM Chinese biotech and the shift in global pharma deals By James Johnston Claire Smith The historical western approach of relying on internally-developed blockbuster drugs to drive growth is now under strain. Patent expiries...
2/16/2026 9:14:09 AM Women’s Health in focus: key themes for 2026 By Sophie Rees Laura Harwood Ellie Handy The women’s health sector is undergoing significant transformation. A major driving force for this is the evolution of AI and the impact...
2/13/2026 3:08:56 PM Immigration reforms: upcoming and recent developments By Mohammad Aljamal Since the Government’s pledge to “restore control to our borders”, the immigration rules have been amended and far-reaching changes to...
2/13/2026 10:49:00 AM Off the cliff, into the deal room: pharma M&A in 2026 and beyond By Mohammad Aljamal The global biopharmaceutical industry entered 2026 facing one of the largest waves of patent expirations in its history. The potential...